Pharmacokinetics and pharmacodynamics of temocapril during repeated dosing in elderly hypertensive patients

European Journal of Clinical Pharmacology

Volumn 56, Issue 11, 2001, Pages 775-779

  Arakawa, Masashi ^a   Sasaki, Masato ^a   Ohmori, Masami ^a   Harada, Kazuhiro ^a   Fujimura, Akio ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Elderly patients; Hypertension; Temocapril

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; TEMOCAPRIL; THIAZEPINE DERIVATIVE;

ADULT; AGED; AGING; AREA UNDER THE CURVE; ARTICLE; BLOOD; BLOOD PRESSURE; BODY WEIGHT; CLINICAL TRIAL; COMPARATIVE STUDY; DRUG ADMINISTRATION; DRUG EFFECT; FEMALE; HALF LIFE TIME; HUMAN; HYPERTENSION; MALE; METABOLISM; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ADULT; AGED; AGING; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; AREA UNDER CURVE; BLOOD PRESSURE; BODY WEIGHT; DRUG ADMINISTRATION SCHEDULE; FEMALE; HALF-LIFE; HUMANS; HYPERTENSION; MALE; THIAZEPINES;

EID: 0034465962     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280000237     Document Type: Article

References (13)

1. Todd PA, Heel RC (1986) Enalapril. Drugs 31: 198-248
2. Suzuki H, Kawaratani T, Shioya H, Uji Y, Saruta T (1993) Study on pharmacokinetics of a new biliary excreted oral angiotensin converting enzyme inhibitor, temocapril (CS-622) in humans. Biopharm Drug Dispos 14: 41-50
3. Oguchi H, Miyasaka M, Koiwai T, Tokunaga S, Hora K, Sato K. et al (1993) Pharmacokinetics of temocapril and enalapril in patients with various degrees of renal insufficiency. Clin Pharmacokinet 24: 421-427
4. Hockings N, Ajayi LAA, Hughes DM, Lees KR, Reid JL (1985) Effects of age on the pharmacodynamic responses to the angiotensin converting enzyme inhibitors enalapril and enalaprilat. Br J Clin Pharmacol 19: 140
5. Hockings N, Ajayi LAA, Reid JL (1985) The effects of age-on the pharmacokinetics and dynamics of the angiotensin converting enzyme inhibitors enalapril and enalaprilat. Br J Clin Pharmacol 20: 262-263
6. Püchler K, Sierakowski B, Roots I (1998) Single dose and steady state pharmacokinetics of temocapril and temocaprilat in young and elderly hypertensive patients. Br J Clin Pharmacol 46: 363-367
7. Shioya H, Shimojo M, Kawahara Y (1991) Determination in plasma of angiotensin-converting enzyme inhibitor by inhibitor-binding assay. J Chromatogr 568: 309-314
8. Brown BW, Hollander M (1977) Statistics: a biomedical introduction. John Wiley and Sons. New York
9. Nakashima M, Yamamoto J, Shibata M, Uematsu T, Shinjo H, Akaliori T, et al (1992) Pharmacokinetics of temocapril hydrochloride, a novel angiotensin converting enzyme inhibitor, in renal insufficiency. Eur J Clin Pharmacol 43: 657-659
10. Lancaster SG, Todd PA (1998) Lisinopril. Drugs 35: 646-669
11. Ishizuka H, Konno K, Naganuma H, Nishimura K, Kouzuki H, Suzuki H, et al (1998) Transport of temocaprilat into rat hepatocytes: role of organic anion transporting polypeptide. J Pharmacol Exp Ther 287: 37-42
12. Ishizuka H, Konno K, Naganuma H, Sasahara K, Kawahara Y, Niinuma K. et al (1997) Temocaprilat, a novel angiotensin-converting enzyme inhibitor, is excreted in bile via an ATP-dependent active transporter (cMOAT) that is deficient in Eisai Hyperbilirubinemic Mutant Rats (EHBR). J Pharmacol Exp Ther 280: 1304-1311
13. Heymes C, Swynghedauw B, Chevalier B (1994) Activation of angiotensinogen and angiotensin-converting enzyme gene expression in the left ventricle of senescent rats. Circulation 90: 1328-1333